A citation-based method for searching scientific literature

Javier Valdés-Ferrada, Natalia Muñoz-Durango, Alejandra Pérez-Sepulveda, Sabrina Muñiz, Irenice Coronado-Arrázola, Francisco Acevedo, Jorge A Soto, Susan M Bueno, Cesar Sánchez, Alexis M Kalergis. Front Immunol 2020
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
Peter Schmid, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Carlos H Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright,[...]. N Engl J Med 2018
50

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
H H Lee, H Dadgostar, Q Cheng, J Shu, G Cheng. Proc Natl Acad Sci U S A 1999
466
25

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
25

Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response.
Patricio Godoy, Cristina Cadenas, Birte Hellwig, Rosemarie Marchan, Joanna Stewart, Raymond Reif, Miriam Lohr, Matthias Gehrmann, Jörg Rahnenführer, Markus Schmidt,[...]. Breast Cancer 2014
53
25

Th17 cells regulate the production of CXCL1 in breast cancer.
Kai Ma, Lihua Yang, Ruowu Shen, Bin Kong, Wenting Chen, Jie Liang, Guoqing Tang, Bei Zhang. Int Immunopharmacol 2018
10
25

TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells.
Takuya Sekine, André Perez-Potti, Son Nguyen, Jean-Baptiste Gorin, Vincent H Wu, Emma Gostick, Sian Llewellyn-Lacey, Quirin Hammer, Sara Falck-Jones, Sindhu Vangeti,[...]. Sci Immunol 2020
44
25

Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
Stephania Libreros, Ramon Garcia-Areas, Yoshimi Shibata, Roberto Carrio, Marta Torroella-Kouri, Vijaya Iragavarapu-Charyulu. Int J Cancer 2012
62
25

Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25-gene prognostic signatures model.
Yushan Liu, Wenfen Fu, Wei Chen, Yuxiang Lin, Jie Zhang, Chuangui Song. Cancer Med 2021
1
100


Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
25

Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
Sharon A Oldford, J Desmond Robb, Dianne Codner, Veeresh Gadag, Peter H Watson, Sheila Drover. Int Immunol 2006
50
25

Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kyungsoo Kim, Seyeon Park, Seong Yong Park, Gamin Kim, Su Myeong Park, Jae-Won Cho, Da Hee Kim, Young Min Park, Yoon Woo Koh, Hye Ryun Kim,[...]. Genome Med 2020
38
25

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules.
Andrew E Teschendorff, Sergio Gomez, Alex Arenas, Dorraya El-Ashry, Marcus Schmidt, Mathias Gehrmann, Carlos Caldas. BMC Cancer 2010
93
25

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
25

Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
Si-Qi Qiu, Stijn J H Waaijer, Mieke C Zwager, Elisabeth G E de Vries, Bert van der Vegt, Carolien P Schröder. Cancer Treat Rev 2018
119
25

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.
Marcus Schmidt, Veronika Weyer-Elberich, Jan G Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J Battista, Annette Hasenburg, Ugur Sahin,[...]. Breast Cancer Res 2018
39
25

Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer.
R Verma, R L Bowen, S E Slater, F Mihaimeed, J L Jones. Br Med Bull 2012
23
25

Inferring tumour purity and stromal and immune cell admixture from expression data.
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, Rahulsimham Vegesna, Hoon Kim, Wandaliz Torres-Garcia, Victor Treviño, Hui Shen, Peter W Laird, Douglas A Levine,[...]. Nat Commun 2013
25

Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.
Richard Buus, Ivana Sestak, Ralf Kronenwett, Sean Ferree, Catherine A Schnabel, Frederick L Baehner, Elizabeth A Mallon, Jack Cuzick, Mitch Dowsett. J Clin Oncol 2021
13
25

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne Brain, Sylvain Causeret, Mauro DeLorenzi,[...]. N Engl J Med 2016
809
25

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
Sahar M A Mahmoud, Emma Claire Paish, Desmond G Powe, R Douglas Macmillan, Matthew J Grainge, Andrew H S Lee, Ian O Ellis, Andrew R Green. J Clin Oncol 2011
863
25

Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients.
Fabrice Andre, Narjiss Berrada, Christine Desmedt. Curr Opin Oncol 2010
41
25

The immune contexture in human tumours: impact on clinical outcome.
Wolf Herman Fridman, Franck Pagès, Catherine Sautès-Fridman, Jérôme Galon. Nat Rev Cancer 2012
25

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Brett Wallden, James Storhoff, Torsten Nielsen, Naeem Dowidar, Carl Schaper, Sean Ferree, Shuzhen Liu, Samuel Leung, Gary Geiss, Jacqueline Snider,[...]. BMC Med Genomics 2015
210
25

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.
Marisa M Queen, Randall E Ryan, Ryan G Holzer, Cynthia R Keller-Peck, Cheryl L Jorcyk. Cancer Res 2005
245
25

Higher levels of GATA3 predict better survival in women with breast cancer.
Nam K Yoon, Erin L Maresh, Dejun Shen, Yahya Elshimali, Sophia Apple, Steve Horvath, Vei Mah, Shikha Bose, David Chia, Helena R Chang,[...]. Hum Pathol 2010
107
25

TIMER2.0 for analysis of tumor-infiltrating immune cells.
Taiwen Li, Jingxin Fu, Zexian Zeng, David Cohen, Jing Li, Qianming Chen, Bo Li, X Shirley Liu. Nucleic Acids Res 2020
422
25

Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.
Gaynor J Bates, Stephen B Fox, Cheng Han, Russell D Leek, José F Garcia, Adrian L Harris, Alison H Banham. J Clin Oncol 2006
767
25

Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
Katherine Sanchez, David Page, Heather L McArthur. Curr Probl Cancer 2016
12
25

Clinical relevance of host immunity in breast cancer: from TILs to the clinic.
Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K Darcy, Mark J Smyth, Sherene Loi. Nat Rev Clin Oncol 2016
365
25

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer.
Xiao-Jun Ma, Ranelle Salunga, Sonika Dahiya, Wilson Wang, Erin Carney, Virginie Durbecq, Adrian Harris, Paul Goss, Christos Sotiriou, Mark Erlander,[...]. Clin Cancer Res 2008
202
25

A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Martin Filipits, Margaretha Rudas, Raimund Jakesz, Peter Dubsky, Florian Fitzal, Christian F Singer, Otto Dietze, Richard Greil, Andrea Jelen, Paul Sevelda,[...]. Clin Cancer Res 2011
387
25

Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer.
Shicheng Su, Jianyou Liao, Jiang Liu, Di Huang, Chonghua He, Fei Chen, LinBing Yang, Wei Wu, Jianing Chen, Ling Lin,[...]. Cell Res 2017
80
25

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, Bertrand Routy, Aurélie Fluckiger, Takahiro Yamazaki, Kristina Iribarren, Connie P M Duong, Laetitia Fend, Anne Caignard,[...]. Oncoimmunology 2017
13
25

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
H R Ali, E Provenzano, S-J Dawson, F M Blows, B Liu, M Shah, H M Earl, C J Poole, L Hiller, J A Dunn,[...]. Ann Oncol 2014
379
25

BCL2A1: the underdog in the BCL2 family.
M Vogler. Cell Death Differ 2012
162
25

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
D I Gabrilovich, H L Chen, K R Girgis, H T Cunningham, G M Meny, S Nadaf, D Kavanaugh, D P Carbone. Nat Med 1996
25

Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma.
Benjamin P Fairfax, Chelsea A Taylor, Robert A Watson, Isar Nassiri, Sara Danielli, Hai Fang, Elise A Mahé, Rosalin Cooper, Victoria Woodcock, Zoe Traill,[...]. Nat Med 2020
70
25

Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
Paola Filipazzi, Roberta Valenti, Veronica Huber, Lorenzo Pilla, Paola Canese, Manuela Iero, Chiara Castelli, Luigi Mariani, Giorgio Parmiani, Licia Rivoltini. J Clin Oncol 2007
508
25

Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling.
Olga V Britanova, Ekaterina V Putintseva, Mikhail Shugay, Ekaterina M Merzlyak, Maria A Turchaninova, Dmitriy B Staroverov, Dmitriy A Bolotin, Sergey Lukyanov, Ekaterina A Bogdanova, Ilgar Z Mamedov,[...]. J Immunol 2014
202
25

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
Lars A Ormandy, Tina Hillemann, Heiner Wedemeyer, Michael P Manns, Tim F Greten, Firouzeh Korangy. Cancer Res 2005
473
25

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
Isabel Poschke, Dimitrios Mougiakakos, Johan Hansson, Giuseppe V Masucci, Rolf Kiessling. Cancer Res 2010
305
25

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason J Luke, Thomas F Gajewski. Science 2018
957
25


Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Matthew H Spitzer, Yaron Carmi, Nathan E Reticker-Flynn, Serena S Kwek, Deepthi Madhireddy, Maria M Martins, Pier Federico Gherardini, Tyler R Prestwood, Jonathan Chabon, Sean C Bendall,[...]. Cell 2017
402
25

Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells.
Alexander Sio, Manreet K Chehal, Kevin Tsai, Xueling Fan, Morgan E Roberts, Brad H Nelson, Jolanta Grembecka, Tomasz Cierpicki, Danielle L Krebs, Kenneth W Harder. Cancer Res 2013
25
25

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.
Lukas F Mager, Regula Burkhard, Nicola Pett, Noah C A Cooke, Kirsty Brown, Hena Ramay, Seungil Paik, John Stagg, Ryan A Groves, Marco Gallo,[...]. Science 2020
133
25

Utility of influenza vaccination for oncology patients.
Daniel A Pollyea, Janice M Y Brown, Sandra J Horning. J Clin Oncol 2010
84
25

The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer.
Hye Ryun Kim, Su-Myeong Park, Sang-Uk Seo, Inkyung Jung, Hong In Yoon, Dmitry I Gabrilovich, Byoung Chul Cho, Seung-Yong Seong, Sang-Jun Ha, Je-In Youn. Am J Respir Crit Care Med 2019
37
25

Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice.
Efimia Boutsikou, Kalliopi Domvri, Georgia Hardavella, Dora Tsiouda, Konstantinos Zarogoulidis, Theodoros Kontakiotis. Ther Adv Med Oncol 2018
33
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.